mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
0.0094 |
0.8 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.0079 |
0.8 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
-0.0076 |
0.8 |
mRNA |
BRD-A71883111 |
CTRPv2 |
pan-cancer |
AAC |
0.0085 |
0.8 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0075 |
0.8 |
mRNA |
Mitomycin-C |
GDSC1000 |
pan-cancer |
AAC |
-0.0076 |
0.8 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0078 |
0.8 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.0071 |
0.8 |
mRNA |
ATRA |
FIMM |
pan-cancer |
AAC |
-0.041 |
0.8 |
mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
0.0066 |
0.8 |